Bacil Pharma (BACPHAR) | Stock Overview & Key Data

Bacil Pharma Ltd. | Small-cap | Healthcare

₹36.90

-1.60%

Bacil Pharma vs Sun Pharmaceutical Bacil Pharma vs Divi's Laboratories Bacil Pharma vs Sun Pharma Advanced Bacil Pharma vs Sequent Scientific Bacil Pharma vs Aarti Drugs Bacil Pharma vs NIFTY 50 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Bacil Pharma Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	Bacil Pharma	Healthcare Sector	NIFTY 50
1 Week	-1.60%	N/A	N/A
1 Month	-1.81%	N/A	N/A
3 Months	-11.19%	N/A	N/A
6 Months	-11.53%	N/A	N/A
1 Year	92.79%	N/A	N/A
3 Years	766.20%	N/A	N/A
5 Years	1,146.62%	N/A	N/A

Stock Range

Today's Range

Low: ₹35.80 High: ₹37.00

on August 25, 2025

52 Week Range

Low: ₹16.24 High: ₹62.56

on August 26, 2024

on December 19, 2024

All-Time High: ₹62.56 on December 16, 2024

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR217.3M

EPS i 1.23

P/E Ratio (TTM) i 30.00

Forward P/E i N/A

P/B Ratio i 1.13

PEG Ratio i -0.03

Div. Yield i N/A

ROE i 1.59%

Beta i 0.295

Debt to Equity i 0.64

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i -10.86%

Profit Margin i 111.61%

Returns and Earnings

Return on Assets (TTM) i 1.58%

Return on Equity (TTM) i 1.59%

EBITDA i INR-3.2M

Net Income (TTM) i INR11.1M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i INR1.68

Quarterly Revenue Growth (YoY) i N/A

Quarterly Earnings Growth (YoY) i N/A

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Bacil Pharma BACPHAR	217.34M Small-cap	-1.60%	-1.81%	-11.19%	-11.53%	-30.72%	92.79%	766.20%	1,146.62%
Sun Pharmaceutical SUNPHARMA	3.84T Large-cap	-2.88%	-6.78%	-6.19%	0.08%	-15.63%	-12.47%	83.37%	211.15%
Divi's Laboratories DIVISLAB	1.64T Large-cap	-0.33%	-8.16%	-7.54%	11.88%	0.96%	20.37%	70.41%	90.23%
Sun Pharma Advanced SPARC	45.62B Small-cap	-4.10%	-8.75%	-22.48%	24.65%	-30.20%	-36.71%	-38.11%	-20.20%
Sequent Scientific SEQUENT	43.49B Small-cap	-3.68%	-4.25%	-12.89%	13.97%	-8.28%	3.51%	47.92%	26.44%
Aarti Drugs AARTIDRUGS	42.86B Small-cap	-2.79%	-12.89%	-0.75%	33.64%	3.08%	-19.43%	7.76%	-34.26%

Ownership & Short Interest

Insider Ownership i 14.71%

Institutional Ownership i 0.00%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 29K

Average 90-Day Volume i 32K

Bacil Pharma Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Bacil Pharma would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of Bacil Pharma, please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: -1.60%
1 Month: -1.81%
3 Months: -11.19%
1 Year: 92.79%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is BACPHAR's 52-week high and low?

In the last 52 weeks, Bacil Pharma reached a high of ₹62.56 (on December 19, 2024) and a low of ₹16.24 (on August 26, 2024).

What is the market cap and P/E ratio for BACPHAR?

Curious about Bacil Pharma's size and valuation? Its market capitalization stands at 217.34M. When it comes to valuation, the P/E ratio (trailing twelve months) is 30.00, and the forward P/E (looking ahead) is N/A.

Does BACPHAR pay dividends? If so, what's the yield?

As for dividends, Bacil Pharma isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Bacil Pharma's main competitors or similar companies to consider before investing?

When looking at Bacil Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Sun Pharmaceutical SUNPHARMA	3.84T	Healthcare	Drug Manufacturers - Specialty & Generic	-12.47%	83.37%
Divi's Laboratories DIVISLAB	1.64T	Healthcare	Drug Manufacturers - Specialty & Generic	20.37%	70.41%
Sun Pharma Advanced SPARC	45.62B	Healthcare	Drug Manufacturers - Specialty & Generic	-36.71%	-38.11%
Sequent Scientific SEQUENT	43.49B	Healthcare	Drug Manufacturers - Specialty & Generic	3.51%	47.92%
Aarti Drugs AARTIDRUGS	42.86B	Healthcare	Drug Manufacturers - Specialty & Generic	-19.43%	7.76%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Bacil Pharma Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of Bacil Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.59%, the Debt to Equity ratio from the most recent quarter is 0.64, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for BACPHAR?

Looking at Bacil Pharma's growth, its revenue over the trailing twelve months (TTM) was INR10M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of BACPHAR stock is held by insiders and institutions?

Wondering who owns Bacil Pharma stock? Company insiders (like executives and directors) hold about 14.71% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.